CRDL
HealthcareCardiol Therapeutics Inc.
$1.00
+$0.01 (+0.60%)
Jan 5, 2026
Price History (1Y)
Analysis
Cardiol Therapeutics Inc. is a healthcare company operating in the drug manufacturers - specialty & generic sector. The company has a market capitalization of $100.00M and employs 18 individuals. The financial health of Cardiol Therapeutics Inc. indicates significant losses, with net income totaling -$34,784,616 over the trailing twelve months (TTM). The company's margins are also at 0.0% for gross margin, operating margin, and profit margin. Return on Equity (ROE) is -348.0%, and Return on Assets (ROA) stands at -148.8%. Cardiol Therapeutics Inc. has a debt-to-equity ratio of 1.40 and $134,199 in debt, against cash reserves of $11.62M. The valuation context for Cardiol Therapeutics Inc. includes a forward P/E ratio of -3.68 and an EV/EBITDA of -2.07. The company's price to book is 12.61. The 52-week high is $1.59, while the 52-week low is $0.77, with a beta value of 0.82.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.
Visit website →Key Statistics
- Market Cap
- $100.00M
- P/E Ratio
- N/A
- 52-Week High
- $1.59
- 52-Week Low
- $0.77
- Avg Volume
- 584.42K
- Beta
- 0.82
Company Info
- Exchange
- NCM
- Country
- Canada
- Employees
- 18